Emily Souther Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 410 Pine Dr, Evans, WV 25241 Phone: 304-532-3614 |
News Archive
In a new study, researchers show that engineered nanosponges that are encapsulated in the membranes of red blood cells can reduce the severity of infections caused by group A Streptococcus, the bacteria responsible for strep throat and life-threatening infections such as necrotizing fasciitis, or flesh-eating disease.
More than 1 million people undergo total joint replacements each year, and nearly 10,000 will develop infections. To reduce this infection risk, a Houston Methodist orthopedic surgeon created small antibiotic beads that are implanted with the new joint to slowly release medicine for several weeks.
Elderly drivers are half as likely to see pedestrians on the sidewalk due to a limited field of view, and compensate in part by driving more slowly, according to a study by Ben-Gurion University of the Negev researchers.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its tumor-targeting pro-drug candidate INNO-206 has been approved for orphan drug designation for the treatment of patients with pancreatic cancer by the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA). CytRx holds the exclusive worldwide development and commercialization rights to INNO-206.
› Verified 9 days ago